Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients

Not Applicable

Not yet recruiting

Brief Summary: In this research, we will evaluate the feasibility of following by remote monitoring, using a connected scale, in hematology patients suffering from myeloma or lymphoma and requiring treatment with chemotherapy. 30 patients will be included in the research and will all use a connected scale for the duration of their participation (7 weeks +/- 1 week). During their participation, patients will be asked to weigh themselves once a day, ideally at a set time. Patient data will be accessible by the medical team via a remote monitoring platform.

Alerts will be generated in the event of abnormal development of certain clinical parameters (weight, heart rate, etc.) allowing early treatment to be implemented by the medical team.

At the end of their participation, we will evaluate patients' support and perception of this tool, as well as the healthcare consequences of the alerts generated by the remote monitoring platform.

Recruitment & Eligibility

Inclusion Criteria

Patient aged 18 and over (male or female)
Patient suffering from aggressive non-Hodgkin's lymphoma or multiple myeloma with a plan for systemic chemotherapy or having started two cycles or less or patient with the need for therapeutic intensification under the cover of autograft in the context of myeloma or lymphoma
Patient who can be contacted by telephone during their participation in the research
Patient able to return home at the end of their initial hospitalization
Patient affiliated to social security
Patient able to read and speak French
Patient having signed free, informed and written consent

Exclusion Criteria

Patient with an estimated life expectancy < 3 months
Patient with moderate to severe cognitive impairment (assessed by MMSE < 20)
Patient with a psychiatric or physical disability that does not allow the use of the device
Patient with a pacemaker
Patient participating in another intervention research project
Pregnant patient
Patient deprived of liberty
Patient under legal protection (guardianship or curatorship)

Arm && Interventions

Group	Intervention	Description
Cohort group	Connected scale "Body Comp Pro" from Withings	Patients will be used a connected scale during the duration of their participation in the study. Patients will be invited to use the scale once a day. Patient's data will be accesible by medical team via a specific remote plateform. Alert will be generated according to the evolution of clinical data, permetting a early patient management by the medical team.

Primary Outcome Measures

Name	Time	Method
Percentage of patients who agreed to participate in research	Inclusion	Number of included patients / Number of indormed patients

Secondary Outcome Measures

Name	Time	Method
Evaluation of the ease of use of the device perceived by the patient	week 7	Symptom Usability Scale (0 - 100 ; Higher score mean a better outcome)
Assessment of the patient's anxiety regarding the device	week 7	Specific 5 points Likert Scale (1 - 5 ; Higher score mean a worse outcome)
Evaluation of the implementation of the study by the patient	week 7	FIM (Feasibility of Intervention Measure), AIM (Acceptability of Intervention Measure) and IAM (Intervention Appropriateness Measure) / (1 - 5 ; Higher score mean a better outcome)
Evaluation of the consequences in care of alerts generated by the plateform	From inclusion to week 7	Number and type of consultations, hospitalizations, additional assessments resulting from the generation of an alert.
Frequency of use of the connected scale during the patient's participation in the research	From inclusion to week 7	Average of weighings/week

Receive instant email notifications about changes in this clinical trial

Receive instant email notifications about changes in this clinical trial